Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
Open Access
- 26 April 2020
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 14 (6), 1185-1206
- https://doi.org/10.1002/1878-0261.12696
Abstract
Increasing evidence suggests that interference with growth factor receptor tyrosine kinases (RTKs) signaling can affect DNA damage response (DDR) networks, with a consequent impact on cellular responses to DNA‐damaging agents widely used in cancer treatment. In that respect, the MET RTK is deregulated in abundance and/or activity in a variety of human tumors. Using two proteomic techniques, we explored how disrupting MET signaling modulates global cellular phosphorylation response to ionizing radiation (IR). Following an immunoaffinity‐based phosphoproteomic discovery survey we selected candidate phosphorylation sites for extensive characterization by targeted proteomics focusing on phosphorylation sites in both signaling networks. Several substrates of the DDR were confirmed to be modulated by sequential MET inhibition and IR, or MET inhibition alone. Upon combined treatment, for two substrates, NUMA1 S395 and CHEK1 S345, the gain and loss of phosphorylation, respectively, were recapitulated using in vivo tumor models by immunohistochemistry, with possible utility in future translational research. Overall, we have corroborated phosphorylation sites at the intersection between MET and the DDR signaling networks, and suggest that these represent a class of proteins at the interface between oncogene‐driven proliferation and genomic stability.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030B_147086, 31003A_156816, 31003A_166435)
This publication has 90 references indexed in Scilit:
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling NetworksCell, 2012
- Proteomic Investigations Reveal a Role for RNA Processing Factor THRAP3 in the DNA Damage ResponseMolecular Cell, 2012
- Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perilsEMBO Molecular Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant EnvironmentJournal of Proteome Research, 2011
- Site-specific Phosphorylation Dynamics of the Nuclear Proteome during the DNA Damage ResponseMolecular & Cellular Proteomics, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Receptor signaling as a regulatory mechanism of DNA repairRadiotherapy and Oncology, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activationProceedings of the National Academy of Sciences of the United States of America, 2008